Acquisition of Active Medical shares and making it a wholly owned subsidiary
First written in FY2020-Q2. 5 of 10 entries say "Restated". Latest entry: FY2026-H1.
No other company in this theme has enough history to compare yet.
- FY2026-H1AdvancedAnnual report
「We have decided to proceed with this merger after determining that integrating the management resources of both companies and establishing a more comprehensive medical device sales structure would contribute to accelerating market-share growth by contributing to the healthcare sector in Hokkaido.」
An absorption-type merger integrating the management resources of Active Medical and Noah International was completed on 1 October 2025, with the surviving company changing its corporate name to エーノースメディカル. The reorganisation aimed at establishing a comprehensive sales structure in Hokkaido and expanding market share has entered the implementation stage. - FY2022RestatedAnnual report
「With former ㈱アクティブメディカル as the surviving company, ㈱オズ, イーバスメディカル㈱ and ディーセンス㈱ were merged by absorption, and the surviving company changed its corporate name to ㈱アルバース.」
The integration of the 4 companies in the cardiovascular field, the company split of the Hokkaido business, and the restructuring involving the name changes to アルバース and アクティブメディカル continue to be reported as completed. - FY2022-Q3RestatedAnnual report
「During the second quarter consolidated accounting period, the company carried out an absorption-type merger in which its consolidated subsidiary アクティブメディカル Co., Ltd. was the surviving company and its consolidated subsidiaries オズ Co., Ltd., イーバスメディカル Co., Ltd. and ディーセンス Co., Ltd. were the absorbed companies, and changed the corporate name to アルバース Co., Ltd. In connection with this, the Hokkaido business of アクティブメディカル Co., Ltd. was transferred through a company split to the consolidated subsidiary アクティブメディカル分割準備 Co., Ltd., which then changed its corporate name to アクティブメディカル Co., Ltd.」
The company reconfirms that the four-company integration in the cardiovascular field, the company split of the Hokkaido business, and the corporate name changes to アルバース and アクティブメディカル have been completed. - FY2022-Q2RestatedAnnual report
「During the second quarter, the company conducted an absorption-type merger in which its consolidated subsidiary アクティブメディカル was the surviving company and its consolidated subsidiaries オズ, イーバスメディカル㈱ and ディーセンス㈱ were absorbed companies, and changed the corporate name to ㈱アルバース.」
The company reconfirms that it carried out a four-company restructuring with アクティブメディカル as the surviving company and changed the surviving company's name to アルバース. - FY2022-Q1AchievedAnnual report
「Based on a resolution of the Board of Directors adopted at its meeting on 20 April 2021, the company carried out, effective 1 October 2021, an absorption-type merger in which its consolidated subsidiary アクティブメディカル Co., Ltd. was the surviving company and オズ Co., Ltd., イーバスメディカル Co., Ltd. and ディーセンス Co., Ltd. were the absorbed companies.」
Effective 1 October 2021, the company carried out a four-company restructuring in which アクティブメディカル was the surviving company and absorbed オズ, イーバスメディカル and ディーセンス, and changed the surviving company's corporate name to アルバース Co., Ltd. - FY2021AdvancedAnnual report
「At a meeting of the Board of Directors held on 20 April 2021, the company resolved that its consolidated subsidiary アクティブメディカル Co., Ltd. would absorb オズ Co., Ltd., イーバスメディカル Co., Ltd. and ディーセンス Co., Ltd. through a merger.」
The company resolved on a four-company restructuring in which アクティブメディカル would be the surviving company and absorb オズ, イーバスメディカル and ディーセンス. The effective date was scheduled for 1 October 2021, after which the combined company would be named アルバース Co., Ltd. - FY2021-Q3RestatedAnnual report
「Although sales of consumables in the medical-equipment sales business were affected by a decline in surgical cases resulting from the spread of COVID-19, sales and gross profit increased year on year because of higher sales following the acquisition of SPD contracts and new customers, the establishment of new sales offices, and the integration with ㈱アクティブメディカル.」
The management integration with アクティブメディカル continues to be cited as a factor behind the increase in sales of consumables, together with SPD, new customers and the establishment of new sales offices. - FY2020RestatedAnnual report
「The business combination took place on 31 March 2020.」
The annual report also confirms that the acquisition of all issued shares of アクティブメディカル and its conversion into a wholly owned subsidiary were completed on 31 March 2020. - FY2020-Q3AchievedAnnual report
「Following the acquisition of all shares of ㈱アクティブメディカル effective 31 March 2020, the Company included it in the scope of consolidation from the third quarter of the current fiscal year.」
The company completed the previously decided acquisition of all issued shares of アクティブメディカル on 31 March 2020, making it a consolidated subsidiary. - FY2020-Q2First statedAnnual report
「アクティブメディカル operates primarily in the cardiovascular field in the Tokyo metropolitan area and Hokkaido. The company decided to acquire the shares after determining that making it a subsidiary would expand its sales share in the cardiovascular field in the Tokyo metropolitan area and further strengthen its procurement capabilities, while also contributing to an increase in enterprise value across the group through the sharing of expertise and mutual use of customer bases. Business combination date Scheduled for February 2020 (share acquisition date) Voting rights acquired 100.00%」
The company first disclosed its plan to acquire all issued shares of アクティブメディカル for cash, with the aim of expanding its sales share in the cardiovascular field in the Tokyo metropolitan area, strengthening procurement capabilities and making mutual use of customer bases.